TB-500

TB-500 Peptide: A Scientific Overview

TB-500 is a laboratory-synthesized, small peptide derived from the active segment of thymosin beta-4 (T beta 4), a protein found naturally within nearly all eukaryotic cells. As an optimized analogue, TB-500 is focused on the core biological function of the 43-amino acid T beta 4 protein. It is widely investigated for its potential regulatory effects on fundamental processes, including cellular repair, motility (cell movement), and angiogenesis (the formation of new blood vessels). Preclinical research specifically targets its application in accelerating and enhancing the recovery of injured tissues, such as skeletal muscle, ligaments, tendons, and myocardial tissue.

TB-500 Peptide - 10mg Overview

The 10mg preparation of TB-500 is the synthesized, seven-amino-acid sequence: LKKETEQ. This sequence represents residues 17–23 of thymosin beta-4, which constitutes the region primarily responsible for binding to actin. In laboratory models, this active fragment is hypothesized to precisely modulate the process of actin polymerization. This cytoskeletal management is essential for enhancing the directed migration of restorative cells to damaged areas, which is a rate-limiting step in successful tissue repair.

Moreover, published research suggests TB-500's action extends to gene regulation, potentially increasing the expression of microRNA-146a. This microRNA is implicated in controlling inflammatory signaling pathways, thereby contributing to the peptide’s observed ability to promote endothelial cell growth, neovascularization, and efficient wound resolution. Compared to the native protein, TB-500 is a truncated analogue engineered for superior stability and targeted bioactivity in complex in vitro and in vivo research protocols.

TB-500 Peptide Mechanism of Action

TB-500 functions primarily as an actin-sequestering agent, mirroring the central role of its parent protein, T beta 4. Actin is a principal protein in the cytoskeleton, forming microfilaments that are indispensable for cellular architecture, mechanical stability, and directed movement.

By binding individual actin monomers, TB-500 protects these units from degradation and maintains them in a large, readily mobilized reserve pool. This protective sequestration ensures a critical supply of actin is instantly available for rapid assembly into new microfilaments (polymerization) when the cell is signaled to move or change shape, which is vital for the rapid response to injury and subsequent tissue reconstruction.

Feature

Thymosin Beta-4 (T beta 4)

TB-500 Peptide

Origin

Endogenous Mammalian Protein

Optimized Synthetic Fragment

Molecular Weight

Larger (43 AAs)

Smaller (7 AAs)

Key Cellular Role

Actin-sequestering

Targeted Actin-sequestering

Research Benefit

Study of native signaling

Enhanced stability and targeted function

TB-500 (Thymosin Beta-4) Peptide Sequence

The definitive, active amino acid sequence of the TB-500 heptapeptide is:

L-Lys-Lys-Glu-Thr-Glu-Gln-Lys

This sequence corresponds to the key functional residues 17 through 23 of the full-length, naturally occurring thymosin beta-4.

TB-500 Structure Solution Formula (Example for 10mg/mL Concentration):

To obtain a highly concentrated 10mg per milliliter solution, reconstitute 10mg of lyophilized TB-500 powder with 1 milliliter of an appropriate sterile solvent, such as Bacteriostatic Water for Injection.

TB-500 Research

1. TB-500 and Neurologic Function

Studies have shown TB-500 promotes repair and remodeling in the central and peripheral nervous systems post-injury. Research suggests TB-500 activates oligodendrocytes (neuronal support cells) and enhances neovascularization and neuronal sprouting, which correlates with improvements in motor function, cognition, and behavior in animal models. Further work indicates it may reduce oxidative stress and improve the viability of transplanted neural stem cells, suggesting potential for spinal regeneration research.

2. TB-500 and Blood Vessel Growth

TB-500 is known to be a strong inducer of VEGF, a molecule critical for capillary formation. However, its role is theorized to be broader, supporting all phases of vascular development, including extracellular matrix remodeling and the differentiation of progenitor cells into endothelial cells. Research confirms T beta 4 is essential for vascular stability, and its administration enhances capillary formation at injury sites.

3. TB-500 and Hair Growth

The peptide's influence was noted in mice lacking T beta 4, which exhibited retarded hair regrowth, while mice with T beta 4 overexpression showed accelerated regrowth and higher follicle density. This demonstrates a direct link to the regulation of the hair follicle cycling process.

4. TB-500 and Antibiotic Synergy

Addressing rising antibiotic resistance, studies have demonstrated that combining T beta 4 with conventional antibiotics, like ciprofloxacin, significantly boosted the antibiotic's efficacy, accelerated healing, and reduced inflammation in models of P. aeruginosa infection. This suggests a potential synergistic role for TB-500 analogues in infectious disease research.

5. TB-500 and Cardiovascular Health

Decades of research highlight T beta 4's benefits for the cardiovascular and renal systems. Key mechanisms include promoting collateral blood vessel growth, enhancing endothelial cell migration, and improving cardiomyocyte survival after myocardial infarction. It also helps modulate inflammation and limits fibrosis (scar tissue formation).

6. TB-500 and Neurodegenerative Diseases

Research has demonstrated that T beta 4 enhances autophagy, a crucial cellular self-cleaning mechanism and the nervous system's defense against neurodegeneration. By boosting this process, T beta 4 offers a promising research pathway for developing therapeutic strategies against neurodegenerative conditions, such as Alzheimer's.

7. TB-500 Has Wide Application

Due to TB-500's fundamental role in actin regulation across numerous tissue types, its research applications are exceptionally broad. Its studied potential in cardiovascular, neurological, and regenerative medicine confirms its status as one of the most intensively investigated peptides in current biomedical science. TB-500 is for research and laboratory purposes only and is not approved for human or animal use.

Article Author

This literature review was compiled, edited, and organized by Dr. Daniel C. Crockford, Ph.D. Dr. Crockford is a highly respected biomedical scientist known for his extensive research on thymosin beta-4 (T beta 4) and its synthetic counterpart, TB-500. His work has significantly advanced the understanding of the peptide’s role in angiogenesis, tissue regeneration, and cellular repair mechanisms. Dr. Crockford's published research, along with contributions from collaborators including N. Turjman, C. Allan, J. Angel, K.M. Malinda, I. Bock-Marquette, D. Philp, and A.L. Goldstein, has provided foundational knowledge regarding the function of T beta 4 analogues. This acknowledgment is solely for academic recognition and does not imply endorsement, affiliation, or sponsorship by the distributing company.

Reference Citations

• Malinda KM, et al. Thymosin beta 4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364–368. https://www.sciencedirect.com/science/article/pii/S0022202X15405950
• Xu B, et al. Thymosin beta 4 enhances ligament healing in rats. Regul Pept. 2013;184:1-5. https://pubmed.ncbi.nlm.nih.gov/23523891/
• Bock-Marquette I, et al. Thymosin beta 4 activates integrin-linked kinase and promotes cardiac repair. Nature. 2004;432(7016):466-472. https://doi.org/10.1038/nature03000
• Srivastava D, et al. Cardiac repair with thymosin beta 4 and cardiac reprogramming factors. Ann NY Acad Sci. 2012;1270:66-72. https://pubmed.ncbi.nlm.nih.gov/23259435/
• Santra M, et al. Thymosin beta 4 regulation of microRNA-146a in inflammation. J Biol Chem. 2014;289(28):19508-19518. https://pubmed.ncbi.nlm.nih.gov/24860091/
• Philp D, et al. Thymosin beta 4 and tissue regeneration. J Invest Dermatol. 2004;123(4):802-809. https://pubmed.ncbi.nlm.nih.gov/15373782/
• Crockford D, et al. Thymosin beta-4: structure and function review. Ann NY Acad Sci. 2010;1194:179–189. https://pubmed.ncbi.nlm.nih.gov/20536459/
• Goldstein AL, et al. History and development of thymosins. Ann N Y Acad Sci. 2007;1112:1-13. https://pubmed.ncbi.nlm.nih.gov/17656565/
• Bock-Marquette I, et al. Thymosin beta 4 supports myocardial migration and survival. Nature. 2004;432:466-472. https://pubmed.ncbi.nlm.nih.gov/15565145/
• Crockford D, Turjman N, Allan C, Angel J. Thymosin beta 4: structure and function review. Ann N Y Acad Sci. 2010;1194:179-189. https://pubmed.ncbi.nlm.nih.gov/20536459/

REGULATORY DISCLAIMER: ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered are for in-vitro studies only (conducted outside the living body). These products are not medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

STORAGE

Storage Instructions

TB-500 is stabilized via lyophilization (freeze-drying), which preserves its molecular integrity for approximately 3–4 months during standard shipping. Upon reconstitution with bacteriostatic water, the solution must be refrigerated and is typically stable for up to 30 days. The lyophilized powder is generally stable at room temperature for several weeks prior to reconstitution. For maximum long-term preservation, extending over months or years, freezing at -80 degrees Celsius (-112 degrees Fahrenheit) is the optimal environment.

Best Practices For Storing Peptides

Rigorous adherence to storage protocols is vital for maintaining the purity and reliability of the peptide for research use.

Storage State

Recommended Temperature

Maximum Duration

Key Storage Practice

Lyophilized (Short-Term)

Below 4 degrees Celsius (39 degrees Fahrenheit), Refrigerated

Few days to several months

Store away from light and heat

Lyophilized (Long-Term)

-80 degrees Celsius (-112 degrees Fahrenheit), Freezer

Several months to years

Prevent freeze-thaw cycles; avoid auto-defrost freezers

Reconstituted in Solution

4 degrees Celsius (39 degrees Fahrenheit), Refrigerated

Up to 30 days

Use sterile buffers with pH 5-6; minimize air exposure

• 
  Temperature Control: Store peptides in a cold, dry, dark environment. Avoid the temperature fluctuations inherent in frost-free freezers and minimize repeated freeze-thaw cycles.
• Contamination Control: To prevent moisture from condensing onto the peptide, always allow frozen vials to reach room temperature before opening. Minimize air exposure by promptly resealing the container, ideally after flushing with an inert gas (nitrogen or argon).
• Aliquoting: To protect the peptide from degradation caused by repeated handling and temperature shifts, divide the original sample into smaller, single-use aliquots.
• Solution Stability: Peptide solutions degrade faster than the powder. Store solutions in sterile buffers at pH 5-6. Peptides with Cys, Met, or Trp residues should be frozen when not in immediate use.